Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Talazoparib Monotherapy in Metastatic Castration-Resistant Prostate Cancer With DNA Repair Alterations (TALAPRO-1): An Open-Label, Phase 2 TrialLancet Oncol 2021 Sep 01;22(9)1250-1264, JS de Bono, N Mehra, GV Scagliotti, E Castro, T Dorff, A Stirling, A Stenzl, MT Fleming, CS Higano, F Saad, C Buttigliero, IM van Oort, AD Laird, M Mata, HC Chen, CG Healy, A Czibere, K Fizazi
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.